3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
Zoledronic Acid
4
saracatinib
1
radium Ra 223 dichloride
1
odanacatib
1
etelcalcetide hydrochloride
1
cabozantinib
1
Vitamin D
1
Standard of Care
1
Progestins
1
Paclitaxel
1
Hormone Replacement Therapy
1
Exercise
1
Estrogens
1
Estrogen Replacement Therapy
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Denosumab
1
Calcium
1
BHQ880
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Diseases
×
Exercise
×
Clear all
NCT02439112
2020-12-17
EMMY
Zealand University Hospital
Phase NA
Completed
102 enrolled